AIRNA

A bold vision for genetic medicines

AIRNA was founded in 2021, is headquartered in Cambridge, United States, lists 11–50 employees, and has $245.0M in recorded funding across 3 rounds.

Employees
11–50
Founded
2021
Business Model
B2B
Website
airna.com
Total Funding
$245.0M
Last Round
$155.0M Series BApr 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

AIRNA is a clinical-stage biotechnology company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. Founded in 2021 and headquartered in Cambridge, Massachusetts, with research operations in Tübingen, Germany, AIRNA harnesses the body's natural RNA-editing machinery to develop precision medicines. The company's lead program AIR-001 targets alpha-1 antitrypsin deficiency (AATD).

Summary

AIRNA is a Biotech company based in Cambridge, United States, founded in 2021. It lists 11–50 employees. It has raised $245.0M in total across 3 rounds, most recently a $155.0M Series B round in Apr 2025. Investors include Forbion Capital Partners, Venrock and ARCH Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2025
$155.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AIRNA on Indexed.vc
<a href="https://indexed.vc/companies/airna"><img src="https://indexed.vc/api/badge/company/airna" alt="AIRNA on Indexed.vc" width="260" height="76" /></a>